POEMs and Tips

From Other Journals

Postmenopausal Estrogen and Cognitive Function

Am Fam Physician. 2004 Oct 1;70(7):1351.

Clinical Question: Does postmenopausal estrogen therapy improve global cognitive function?

Setting: Outpatient (any)

Study Design: Randomized controlled trial (double-blinded)

Allocation to Groups: Concealed

Synopsis: The Women’s Health Initiative Memory Study previously reported that combined hormone therapy with estrogen and progesterone does not improve global cognitive function in postmenopausal women. To determine the effect of hormone therapy with estrogen alone, 2,947 women 65 to 79 years of age with previous hysterectomy were randomized in double-blind fashion to receive 0.625 mg per day of conjugated equine estrogen or matching placebo. Persons assessing outcomes were blinded to treatment group assignment. Follow-up was complete for more than 95 percent of the study participants for a mean of 5.4 years. Using intention-to-treat analysis, mean Mini-Mental State Examination scores were 0.26 units lower in the estrogen-treated group than in the placebo group (P = .04). The adverse effects of estrogen were more pronounced in women with a lower score on cognitive function at baseline.

Bottom Line: Postmenopausal estrogen therapy does not improve—and may worsen—global cognitive function. Adverse effects may be more pronounced in women with preexisting reduced cognitive function. (Level of Evidence: 1b)

Copyright © 2004 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.